CD146+ Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort.
Publication
, Conference
Ardoin, SP; Povsic, T; Schanberg, LE; Sandborg, CI; Barnhart, H; Yow, E; Evans, G; Mieszkalski, KL; Ilowite, NT; von Scheven, E; Eberhard, BA ...
Published in: ARTHRITIS AND RHEUMATISM
October 1, 2011
Duke Scholars
Published In
ARTHRITIS AND RHEUMATISM
ISSN
0004-3591
Publication Date
October 1, 2011
Volume
63
Issue
10
Start / End Page
S797 / S798
Location
Chicago, IL
Publisher
WILEY-BLACKWELL
Conference Name
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals
Related Subject Headings
- Arthritis & Rheumatology
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ardoin, S. P., Povsic, T., Schanberg, L. E., Sandborg, C. I., Barnhart, H., Yow, E., … Brunner, H. (2011). CD146+ Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort. In ARTHRITIS AND RHEUMATISM (Vol. 63, pp. S797–S798). Chicago, IL: WILEY-BLACKWELL.
Ardoin, Stacy P., Thomas Povsic, Laura E. Schanberg, Christy I. Sandborg, Huiman Barnhart, Eric Yow, Greg Evans, et al. “CD146+ Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort.” In ARTHRITIS AND RHEUMATISM, 63:S797–98. WILEY-BLACKWELL, 2011.
Ardoin SP, Povsic T, Schanberg LE, Sandborg CI, Barnhart H, Yow E, et al. CD146+ Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort. In: ARTHRITIS AND RHEUMATISM. WILEY-BLACKWELL; 2011. p. S797–8.
Ardoin, Stacy P., et al. “CD146+ Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort.” ARTHRITIS AND RHEUMATISM, vol. 63, no. 10, WILEY-BLACKWELL, 2011, pp. S797–98.
Ardoin SP, Povsic T, Schanberg LE, Sandborg CI, Barnhart H, Yow E, Evans G, Mieszkalski KL, Ilowite NT, von Scheven E, Eberhard BA, Imundo LF, Kimura Y, Silverman ED, Bowyer SL, Punaro MG, Singer NG, Sherry DD, McCurdy DK, Klein-Gitelman M, Wallace C, Silver RM, Wagner-Weiner L, Higgins GC, Brunner H. CD146+ Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort. ARTHRITIS AND RHEUMATISM. WILEY-BLACKWELL; 2011. p. S797–S798.
Published In
ARTHRITIS AND RHEUMATISM
ISSN
0004-3591
Publication Date
October 1, 2011
Volume
63
Issue
10
Start / End Page
S797 / S798
Location
Chicago, IL
Publisher
WILEY-BLACKWELL
Conference Name
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals
Related Subject Headings
- Arthritis & Rheumatology
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences